ome

June 2021 Updates

Live interactive webinars with expert insights on prostate cancer, bladder cancer and lung cancer
Experts’ views on developments in EGFR+ NSCLC from June 2021
8 June 2021

Experts’ views on developments in EGFR+ NSCLC from June 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Describe the novel treatment paradigms for patients with EGFR mutations with advanced NSCLC
  • Evaluate the impact of latest advances in the clinical landscape for NSCLC EGFR exon 20 insertion mutations

 

Co-chairs:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)

 

more info...

EM-57446
;